Alzheimer’s disease: clinical update on epidemiology, pathophysiology and diagnosis DOI
Dhamidhu Eratne, Samantha Loi, Sarah Farrand

et al.

Australasian Psychiatry, Journal Year: 2018, Volume and Issue: 26(4), P. 347 - 357

Published: April 3, 2018

Objectives: To provide a clinical update for general psychiatrists on the assessment and diagnosis of Alzheimer’s disease (AD), highlighting current issues regarding epidemiology, risk factors pathophysiology from recent relevant research findings. Conclusions: Psychiatrists can apply their skills training in AD, which is based upon comprehensive comprising history, investigations, cognitive functional assessment, guided by accepted diagnostic criteria.

Language: Английский

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease DOI Creative Commons
Brent R. Stockwell, José Pedro Friedmann Angeli, Hülya Bayır

et al.

Cell, Journal Year: 2017, Volume and Issue: 171(2), P. 273 - 285

Published: Oct. 1, 2017

Language: Английский

Citations

5504

Ferroptosis: mechanisms, biology and role in disease DOI
Xuejun Jiang, Brent R. Stockwell, Marcus Conrad

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2021, Volume and Issue: 22(4), P. 266 - 282

Published: Jan. 25, 2021

Language: Английский

Citations

4434

Ferroptosis: mechanisms and links with diseases DOI Creative Commons

Hong-Fa Yan,

Ting Zou, Qing‐zhang Tuo

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2021, Volume and Issue: 6(1)

Published: Feb. 3, 2021

Abstract Ferroptosis is an iron-dependent cell death, which different from apoptosis, necrosis, autophagy, and other forms of death. The process ferroptotic death defined by the accumulation lethal lipid species derived peroxidation lipids, can be prevented iron chelators (e.g., deferiprone, deferoxamine) small lipophilic antioxidants ferrostatin, liproxstatin). This review summarizes current knowledge about regulatory mechanism ferroptosis its association with several pathways, including iron, lipid, cysteine metabolism. We have further discussed contribution to pathogenesis diseases such as cancer, ischemia/reperfusion, various neurodegenerative Alzheimer’s disease Parkinson’s disease), evaluated therapeutic applications inhibitors in clinics.

Language: Английский

Citations

946

The development of the concept of ferroptosis DOI
Tal Hirschhorn, Brent R. Stockwell

Free Radical Biology and Medicine, Journal Year: 2018, Volume and Issue: 133, P. 130 - 143

Published: Sept. 27, 2018

Language: Английский

Citations

871

Iron homeostasis and oxidative stress: An intimate relationship DOI Creative Commons

Dimitrios Galaris,

Alexandra Barbouti, Kostas Pantopoulos

et al.

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Journal Year: 2019, Volume and Issue: 1866(12), P. 118535 - 118535

Published: Aug. 22, 2019

Language: Английский

Citations

668

History and progress of hypotheses and clinical trials for Alzheimer’s disease DOI Creative Commons
Peipei Liu, Yi Xie, Xiao‐Yan Meng

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2019, Volume and Issue: 4(1)

Published: Aug. 23, 2019

Abstract Alzheimer’s disease (AD) is a neurodegenerative characterized by progressive memory loss along with neuropsychiatric symptoms and decline in activities of daily life. Its main pathological features are cerebral atrophy, amyloid plaques, neurofibrillary tangles the brains patients. There various descriptive hypotheses regarding causes AD, including cholinergic hypothesis, tau propagation mitochondrial cascade calcium homeostasis neurovascular inflammatory metal ion lymphatic system hypothesis. However, ultimate etiology AD remains obscure. In this review, we discuss related clinical trials. Wealthy puzzles lessons have made it possible to develop explanatory theories identify potential strategies for therapeutic interventions AD. The combination hypometabolism autophagy deficiency likely be causative factor We further propose that fluoxetine, selective serotonin reuptake inhibitor, has treat

Language: Английский

Citations

573

Biomedicine Meets Fenton Chemistry DOI
Zhongmin Tang, Peiran Zhao, Han Wang

et al.

Chemical Reviews, Journal Year: 2021, Volume and Issue: 121(4), P. 1981 - 2019

Published: Jan. 25, 2021

Since the first connection between Fenton chemistry and biomedicine, numerous studies have been presented in this field. Comprehensive presentation of guidance from a summary its representative applications cancer therapy would help us understand promote further development This comprehensive review supplies basic information regarding chemistry, including reactions Fenton-like reactions. Subsequently, current progress is discussed, with some corresponding examples presented. Furthermore, strategies for optimizing performance chemodynamic guided by are highlighted. Most importantly, future perspectives on combination biomedicine or wider range catalytic approaches We hope that will attract positive attention materials science, fields tighten their connections.

Language: Английский

Citations

566

Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases DOI Creative Commons
Xiaohua Song,

Dingxin Long

Frontiers in Neuroscience, Journal Year: 2020, Volume and Issue: 14

Published: April 21, 2020

Ferroptosis is a kind of regulated cell death (RCD) caused by the redox state disorder intracellular microenvironment controlled glutathione peroxidase 4 (GPX4), which inhibited iron chelators and lipophilic antioxidants. In addition to classical regulatory mechanisms, new factors for ferroptosis have been discovered in recent years, such as P53 pathway, ATF3/4 Beclin 1 (BECN1) some non-coding RNA. closely related cancer treatment, neurodegenerative diseases, ischemia-reperfusion organ, neurotoxicity, other particular, field diseases treatment has aroused people's interest. The nuclear factor E2 2 (Nrf2/NFE2L2) proved play key role neurodegeneration disease regulation. promotes progression while expression Nrf2 its target genes (Ho-1, Nqo-1, Trx) declined with aging, therefore, there still insufficient evidence networks diseases. this review, we will provide brief overview well an emphasis on mechanism regulating ferroptosis. We also highlight during process investigate theoretical basis further research relationship between treatment.

Language: Английский

Citations

440

Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases DOI
Toshitaka Nakamura, Isao Naguro, Hidenori Ichijo

et al.

Biochimica et Biophysica Acta (BBA) - General Subjects, Journal Year: 2019, Volume and Issue: 1863(9), P. 1398 - 1409

Published: June 20, 2019

Language: Английский

Citations

424

Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death DOI Creative Commons

Anna Martina Battaglia,

Roberta Chirillo, Ilenia Aversa

et al.

Cells, Journal Year: 2020, Volume and Issue: 9(6), P. 1505 - 1505

Published: June 20, 2020

Ferroptosis is a new type of oxidative regulated cell death (RCD) driven by iron-dependent lipid peroxidation. As major sites iron utilization and master regulators metabolism, mitochondria are the main source reactive oxygen species (ROS) and, thus, play role in this RCD. is, indeed, associated with severe damage mitochondrial morphology, bioenergetics, metabolism. Furthermore, dysregulation metabolism considered biochemical feature neurodegenerative diseases linked to ferroptosis. Whether dysfunction can, per se, initiate ferroptosis whether function context-dependent still under debate. Cancer cells accumulate high levels ROS promote their metabolic activity growth. Of note, cancer rewiring often acquired sensitivity This strongly suggests that may act as an adaptive response imbalance constitute promising way eradicate malignant cells. Here, we review current literature on ferroptosis, discuss opportunities potentially use mitochondria-mediated strategy for therapy.

Language: Английский

Citations

416